The Latest in Conference Coverage

When Is the Optimal Time to Start Treatment in Patients With Relapsing-Remitting MS?

October 12, 2018

Multiple Sclerosis

Relapsing-remitting MS best treated within 6 months of onset

October 12, 2018

Multiple Sclerosis

Level of Serum Neurofilament Light Enables Treatment Monitoring

October 11, 2018

Multiple Sclerosis

Mood disorders worsen multiple sclerosis disability

October 11, 2018

Multiple Sclerosis

Revamped MS criteria boost pediatric diagnoses

October 11, 2018

Multiple Sclerosis

No elevated cancer risk with MS therapies in COMBAT-MS data

October 11, 2018

Multiple Sclerosis

How to Correct a Misdiagnosis of MS

September 28, 2018

Multiple Sclerosis

Abnormal Sleep Staging Predicts Fatigue in Patients With MS

September 28, 2018

Multiple Sclerosis

Serum Nf-L shows promise as biomarker for BMT response in MS

August 28, 2018

Multiple Sclerosis

Aspirin May Be an Effective Pretreatment for Exercise in Patients With MS

August 6, 2018

Multiple Sclerosis

A Rational Approach to Starting, Stopping, and Switching DMTs

August 3, 2018

Multiple Sclerosis

Fitbit Flex is feasible, provides nuanced step count data in MS patients

August 1, 2018

Multiple Sclerosis

Lipid Metabolism May Be a Therapeutic Target in MS

July 19, 2018

Multiple Sclerosis

Ozanimod May Provide Better MS Outcomes Than Interferon Beta

July 3, 2018

Multiple Sclerosis

CMSC Guideline Re-Examines Use of Gadolinium-Based Contrast Agents

July 3, 2018

Multiple Sclerosis